✦ LIBER ✦

Pegylated Interferon-Associated Retinopathy in Chronic Hepatitis C Patients

✍ Scribed by Hiroko Ogata; Hiromasa Suzuki; Kimiya Shimizu; Hitoshi Ishikawa; Namiki Izumi; Masayuki Kurosaki

Book ID: 106327241
Publisher: Springer
Year: 2006
Tongue: English
Weight: 244 KB
Volume: 50
Category: Article
ISSN: 0021-5155
DOI: 10.1007/s10384-005-0301-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon plus ribavirin in c

Pegylated interferon plus ribavirin in chronic hepatitis c

✍ Bruce R. Bacon 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 38 KB

Pegylated interferon for treatment in he

Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C

✍ Iftihar Koksal 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Retinopathy in hepatitis C patients due

Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin

✍ Ei Tae Kim; Lee Hoo Kim; Jung Il Lee; Hee Seung Chin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

Chronic hepatitis C: Treatment of pegyla

Chronic hepatitis C: Treatment of pegylated interferon/ ribavirin nonresponders

✍ Mitchell L. Shiffman 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 178 KB

Chronic hepatitis C: Treatment of pegyla

Chronic hepatitis C: Treatment of pegylated interferon/ ribavirin nonresponders

✍ Mitchell L. Shiffman 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 177 KB

Merimepodib, pegylated interferon, and r

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

✍ Vinod K. Rustgi; William M. Lee; Eric Lawitz; Stuart C. Gordon; Nezam Afdhal; Fr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

on behalf of the MErimepodib TRiple cOmbination (METRO) study group Merimepodib (MMPD) is an orally administered, inosine monophosphate dehydrogenase inhibitor that has shown antiviral activity in nonresponders with chronic hepatitis C (CHC) when combined with pegylated interferon alfa 2a (Peg-IFN-a